EPS for Avid Bioservices, Inc. (PPHM) Expected At $-0.14; Provident Financial Services Has 0.97 Sentiment

February 14, 2018 - By Hazel Jackson

Provident Financial Services, Inc. operates as the holding firm for Provident Bank that provides various banking services to individuals, families, and businesses in the United States. The company has market cap of $1.64 billion. The Company’s deposit products include savings, checking, interest-bearing checking, money market deposit, and certificate of deposit accounts, as well as IRA and KEOGH accounts. It has a 17.54 P/E ratio. The companyÂ’s loan portfolio comprises commercial real estate loans that are secured by properties, such as multi-family apartment buildings, office buildings, and retail and industrial properties; commercial business loans; fixed-rate and adjustable-rate mortgage loans collateralized by one- to four-family residential real estate properties; commercial construction loans; and consumer loans consisting of home equity loans, home equity lines of credit, and marine loans.

Analysts expect Avid Bioservices, Inc. (NASDAQ:PPHM) to report $-0.14 EPS on March, 12.They anticipate $0.14 EPS change or 50.00% from last quarter’s $-0.28 EPS. After having $-0.27 EPS previously, Avid Bioservices, Inc.’s analysts see -48.15% EPS growth. The stock increased 0.72% or $0.03 during the last trading session, reaching $4.22. About 93,094 shares traded. Avid Bioservices, Inc. (NASDAQ:PPHM) has risen 44.74% since February 14, 2017 and is uptrending. It has outperformed by 28.04% the S&P500.

Avid Bioservices, Inc. operates as a contract development and manufacturing organization focusing on the development and cGMP manufacture of biopharmaceutical products derived from mammalian cell culture. The company has market cap of $190.80 million. It provides a range of process development, and cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. It currently has negative earnings. The firm produces monoclonal antibodies and recombinant proteins in batch, fed-batch, and perfusion modes; and provides services, including cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing, and regulatory strategy, submission, and support.

Investors sentiment decreased to 0 in Q3 2017. Its down 1.24, from 1.24 in 2017Q2. It fall, as 44 investors sold Avid Bioservices, Inc. shares while 2 reduced holdings. 0 funds opened positions while 0 raised stakes. 165,096 shares or 99.35% less from 25.52 million shares in 2017Q2 were reported. Baxter Bros invested in 0.02% or 21,501 shares. Eqis Cap Mgmt holds 0.02% in Avid Bioservices, Inc. (NASDAQ:PPHM) or 143,595 shares.

The stock increased 0.43% or $0.11 during the last trading session, reaching $25.44. About 57,339 shares traded. Provident Financial Services, Inc. (PFS) has risen 21.62% since February 14, 2017 and is uptrending. It has outperformed by 4.92% the S&P500.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>